Cancer
Neoplasm of Uncertain Histogenesis
CI-CAN-00000034Explore in graph →
Non-malignant20,280 active trials259 approved drugs3,813 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00000034Explore in graph →
Clinical trials
91,351 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00678509 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer | terminated | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00985829 | Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma | completed | Phase 1 | 28 | Shahid Beheshti University of Medical SciencesOTHER | 0 | Dec 22, 2009 | clinicaltrials |
| NCT00289809 | TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients | completed | Phase 1 / Phase 2 | 36 | Istituto Clinico HumanitasOTHER | 1 | Dec 18, 2009 | clinicaltrials |
| NCT00901238 | Intra-arterial Chemotherapy(Chemosurgery) for Retinoblastoma(Chemosurgery) | completed | Phase 1 / Phase 2 | 100 | Weill Medical College of Cornell UniversityOTHER | 1 | Dec 17, 2009 | clinicaltrials |
| NCT00317434 | Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer | terminated | Phase 1 | 12 | University of Alabama at BirminghamOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00684099 | Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 70 | Hellenic Oncology Research GroupOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00706069 | Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer | completed | Phase 1 | 40 | Hellenic Oncology Research GroupOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00667901 | Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery | terminated | Phase 1 | 15 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Dec 11, 2009 | clinicaltrials |
| NCT00116597 | Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma | completed | Phase 1 / Phase 2 | 15 | University Hospital, Basel, SwitzerlandOTHER | 1 | Dec 2, 2009 | clinicaltrials |
| NCT00363974 | Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML | completed | Phase 1 / Phase 2 | 54 | Aegera TherapeuticsINDUSTRY | 2 | Dec 1, 2009 | clinicaltrials |
| NCT00557596 | A Phase 1-2, XIAP Antisense AEG35156 With Gemcitabine in Patients With Advanced Pancreatic Cancer | terminated | Phase 1 / Phase 2 | 48 | Aegera TherapeuticsINDUSTRY | 1 | Dec 1, 2009 | clinicaltrials |
| NCT01022333 | The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers | unknown | Phase 1 | 300 | Women's College HospitalOTHER | 1 | Dec 1, 2009 | clinicaltrials |
| NCT00114153 | Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | completed | Phase 1 | 48 | University of VirginiaOTHER | 1 | Nov 26, 2009 | clinicaltrials |
| NCT00503204 | Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour | completed | Phase 1 | 20 | AstraZenecaINDUSTRY | 2 | Nov 25, 2009 | clinicaltrials |
| NCT00656461 | Phase 1 Study of MKC-1 in Patients With Advanced Cancer | completed | Phase 1 | 24 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Nov 25, 2009 | clinicaltrials |
| NCT00243763 | TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma | terminated | Phase 1 | 64 | NovartisINDUSTRY | 1 | Nov 23, 2009 | clinicaltrials |
| NCT00190671 | A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients | completed | Phase 1 / Phase 2 | 103 | Eli Lilly and CompanyINDUSTRY | 6 | Nov 20, 2009 | clinicaltrials |
| NCT00681252 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer | completed | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00681330 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer | completed | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00681421 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer | completed | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00681577 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer | completed | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Nov 19, 2009 | clinicaltrials |
| NCT01015898 | Short Term Effects of Photodynamic Therapy in Basal Cell Carcinoma | completed | Phase 1 | 28 | Shahid Beheshti University of Medical SciencesOTHER | 0 | Nov 18, 2009 | clinicaltrials |
| NCT00021749 | Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia | completed | Phase 1 / Phase 2 | 40 | Genta IncorporatedINDUSTRY | 1 | Nov 13, 2009 | clinicaltrials |
| NCT01007240 | Antibacterial Properties of Silicon Incorporated With Quaternary Ammonium Polyethylenimine Nanoparticles | unknown | Phase 1 | 10 | Hadassah Medical OrganizationOTHER | 0 | Nov 4, 2009 | clinicaltrials |
| NCT00387153 | Phase 1 Clinical Trial MPC-2130 Treatment of Blood Cancers / Refractory Cancer | terminated | Phase 1 | 8 | Myriad Therapeutics, Inc.INDUSTRY | 1 | Nov 3, 2009 | clinicaltrials |
| NCT00447421 | A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy | terminated | Phase 1 / Phase 2 | 9 | Eli Lilly and CompanyINDUSTRY | 2 | Oct 28, 2009 | clinicaltrials |
| NCT00486564 | Safety Study of Nifurtimox for Relapsed or Refractory Neuroblastoma | completed | Phase 1 | 20 | University of VermontOTHER | 1 | Oct 23, 2009 | clinicaltrials |
| NCT00999843 | Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer | unknown | Phase 1 / Phase 2 | 30 | Fudan UniversityOTHER | 1 | Oct 22, 2009 | clinicaltrials |
| NCT00960167 | A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC) | unknown | Phase 1 | 20 | National Taiwan University HospitalOTHER | 1 | Oct 15, 2009 | clinicaltrials |
| NCT00374699 | Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas | completed | Phase 1 / Phase 2 | 55 | Samsung Medical CenterOTHER | 1 | Oct 14, 2009 | clinicaltrials |
| NCT00003391 | Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 1 | 30 | Weill Medical College of Cornell UniversityOTHER | 1 | Oct 12, 2009 | clinicaltrials |
| NCT00520637 | A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01) | completed | Phase 1 | 34 | Enzon Pharmaceuticals, Inc.INDUSTRY | 1 | Oct 9, 2009 | clinicaltrials |
| NCT00006246 | Busulfan in Treating Children and Adolescents With Refractory CNS Cancer | completed | Phase 1 | 28 | Pediatric Brain Tumor ConsortiumNETWORK | 1 | Oct 7, 2009 | clinicaltrials |
| NCT00988312 | Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma | completed | Phase 1 | 9 | University Hospital Carl Gustav CarusOTHER | 1 | Oct 2, 2009 | clinicaltrials |
| NCT00988455 | Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma With 6 Months Follow-up | completed | Phase 1 / Phase 2 | 28 | Shahid Beheshti University of Medical SciencesOTHER | 0 | Oct 2, 2009 | clinicaltrials |
| NCT00243529 | Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines in Melanoma Patients | completed | Phase 1 / Phase 2 | 64 | Radboud University Medical CenterOTHER | 1 | Sep 29, 2009 | clinicaltrials |
| NCT00465725 | A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors | completed | Phase 1 | 18 | Poniard PharmaceuticalsINDUSTRY | 1 | Sep 24, 2009 | clinicaltrials |
| NCT00471367 | Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877 | terminated | Phase 1 | 44 | AstraZenecaINDUSTRY | 1 | Sep 24, 2009 | clinicaltrials |
| NCT00425347 | Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma | completed | Phase 1 | 35 | Facet BiotechINDUSTRY | 1 | Sep 23, 2009 | clinicaltrials |
| NCT00376103 | Radiation Boost for Newly Diagnosed Glioblastoma Multiforme | terminated | Phase 1 / Phase 2 | 3 | Methodist Healthcare - MemphisOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00421135 | A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer | completed | Phase 1 | 30 | Alaunos TherapeuticsINDUSTRY | 1 | Sep 17, 2009 | clinicaltrials |
| NCT00608803 | Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid Tumors | completed | Phase 1 | 30 | Alaunos TherapeuticsINDUSTRY | 1 | Sep 17, 2009 | clinicaltrials |
| NCT00401739 | Safety, Tolerability and Pharmacokinetics of CSL360 in the Treatment of Acute Myeloid Leukemia | completed | Phase 1 | 40 | CSL LimitedINDUSTRY | 1 | Sep 16, 2009 | clinicaltrials |
| NCT00928603 | Investigative Study of the Role of Focal Therapy for Prostate Cancer Treatment | unknown | Phase 1 | 100 | Università Vita-Salute San RaffaeleOTHER | 1 | Sep 15, 2009 | clinicaltrials |
| NCT00530699 | Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML) | completed | Phase 1 | 30 | AstraZenecaINDUSTRY | 1 | Sep 11, 2009 | clinicaltrials |
| NCT00423410 | A Safety Study of EPC2407, A Anti-Cancer Drug With Vascular Disrupting Activity: In Patients With Advanced Cancer | completed | Phase 1 | 30 | EpiCept CorporationINDUSTRY | 1 | Sep 10, 2009 | clinicaltrials |
| NCT00147875 | Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma | completed | Phase 1 / Phase 2 | 60 | University of CologneOTHER | 1 | Sep 7, 2009 | clinicaltrials |
| NCT00461110 | A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC) | terminated | Phase 1 | 35 | Bristol-Myers SquibbINDUSTRY | 1 | Sep 4, 2009 | clinicaltrials |
| NCT00302172 | ARQ 197 in Subjects With Metastatic Solid Tumors | completed | Phase 1 | 78 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Aug 26, 2009 | clinicaltrials |
| NCT00715832 | A Phase I Cancer Vaccine Study for Patients With Metastatic Breast Cancer | unknown | Phase 1 | 25 | Southern Cancer CenterOTHER | 1 | Aug 26, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Dec 29, 2009source: clinicaltrials